Collaborators

Coordinating Centre: International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France

• Dr Shama Virani
• Dr Paul Brennan
  
  

Serological analyses – Determination of HPV status

• Dr Tim Waterboer, German Cancer Research Center (DKFZ), Heidelberg, Germany
  
  

Genomic profiling of tumours

• Dr D. Neil Hayes, University of Tennessee Health Science Center, Memphis, Tennessee, USA
  
  

Participating studies

1. The Carolina Head and Neck Cancer Epidemiology (CHANCE) Study  
      https://chance2.unc.edu/about-us/

• Dr Andy Olshan, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
• Dr D. Neil Hayes, University of Tennessee, Memphis, Tennessee, USA

2. The University of Pittsburgh case–control study on head and neck cancer

• Dr Brenda Diergaarde, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
  
  

3. The Toronto Mount Sinai-Princess Margaret (MSH-PMH) Head and Neck Cancer Study, Ontario, Canada

• Dr Rayjean J. Hung, Lunenfeld–Tanenbaum Research Institute, Sinai Health, Toronto, Canada
• Dr Geoffrey Liu, Princess Margaret Cancer Centre, Toronto, Canada
• Coordinator: Ms Kiera Murison, Lunenfeld–Tanenbaum Research Institute, Sinai Health, Toronto, Canada
• Coordinator: Ms Martha Pienkowski, Princess Margaret Cancer Centre, Toronto, Canada

4. The Head and Neck 5000 (HN5000) study
      https://www.headandneck5000.org.uk/

• Dr Tom Dudding, University of Bristol, Bristol, United Kingdom
• Dr Miranda Pring, University of Bristol Hospital, Bristol, United Kingdom
• Dr Andy Ness, University of Bristol, Bristol, United Kingdom

5. Alcohol-Related Cancers and Genetic Susceptibility in Europe (ARCAGE) study

• Dr Paul Brennan, International Agency for Research on Cancer/World Health Organization (IARC/WHO), Lyon, France